170 related articles for article (PubMed ID: 12962028)
1. [Therapeutic apheresis in multiple sclerosis].
Nomura K
Nihon Rinsho; 2003 Aug; 61(8):1388-95. PubMed ID: 12962028
[TBL] [Abstract][Full Text] [Related]
2. [The indication of steroid pulse therapy and apheresis therapy for multiple sclerosis].
Ohji S; Nomura K
Nihon Rinsho; 2008 Jun; 66(6):1127-32. PubMed ID: 18540358
[TBL] [Abstract][Full Text] [Related]
3. [Plasmapheresis in acute phase of multiple sclerosis and neuromyelitis optica].
Matsuo H
Nihon Rinsho; 2014 Nov; 72(11):1999-2002. PubMed ID: 25518384
[TBL] [Abstract][Full Text] [Related]
4. Plasmapheresis for neurological disorders.
Schröder A; Linker RA; Gold R
Expert Rev Neurother; 2009 Sep; 9(9):1331-9. PubMed ID: 19769448
[TBL] [Abstract][Full Text] [Related]
5. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
[TBL] [Abstract][Full Text] [Related]
6. A case report of double filtration plasmapheresis in an acute episode of multiple sclerosis.
Ramunni A; De Robertis F; Brescia P; Saliani MT; Amoruso M; Prontera M; Dimonte E; Trojano M; Coratelli P
Ther Apher Dial; 2008 Jun; 12(3):250-4. PubMed ID: 18503704
[TBL] [Abstract][Full Text] [Related]
7. Synergistic immune responses induced by endogenous retrovirus and herpesvirus antigens result in increased production of inflammatory cytokines in multiple sclerosis patients.
Brudek T; Christensen T; Hansen HJ; Petersen T; Møller-Larsen A
Scand J Immunol; 2008 Mar; 67(3):295-303. PubMed ID: 18261041
[TBL] [Abstract][Full Text] [Related]
8. Experience with use of plasmapheresis in chronic progressive multiple sclerosis: the pros.
Khatri BO
Neurology; 1988 Jul; 38(7 Suppl 2):50-2. PubMed ID: 3290715
[TBL] [Abstract][Full Text] [Related]
9. [Apheresis therapy in Guillain-Barré syndrome].
Nagayama H; Katayama Y
Nihon Rinsho; 2008 Jun; 66(6):1195-9. PubMed ID: 18540370
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of double filtration plasmapheresis in patients with anti-aquaporin-4 antibody-positive multiple sclerosis.
Munemoto M; Otaki Y; Kasama S; Nanami M; Tokuyama M; Yahiro M; Hasuike Y; Kuragano T; Yoshikawa H; Nonoguchi H; Nakanishi T
J Clin Neurosci; 2011 Apr; 18(4):478-80. PubMed ID: 21315606
[TBL] [Abstract][Full Text] [Related]
11. Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome.
Okamiya S; Ogino M; Ogino Y; Irie S; Kanazawa N; Saito T; Sakai F
Ther Apher Dial; 2004 Jun; 8(3):248-53. PubMed ID: 15154879
[TBL] [Abstract][Full Text] [Related]
12. Th1/Th2 cytokine patterns and clinical profiles during and after pregnancy in women with multiple sclerosis.
Al-Shammri S; Rawoot P; Azizieh F; AbuQoora A; Hanna M; Saminathan TR; Raghupathy R
J Neurol Sci; 2004 Jul; 222(1-2):21-7. PubMed ID: 15240191
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma and interleukin-4-producing T cells in peripheral blood of multiple sclerosis patients.
Franciotta D; Zardini E; Bergamaschi R; Andreoni L; Cosi V
Eur Cytokine Netw; 2000 Dec; 11(4):677-81. PubMed ID: 11125313
[TBL] [Abstract][Full Text] [Related]
14. Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis.
Trebst C; Reising A; Kielstein JT; Hafer C; Stangel M
Blood Purif; 2009; 28(2):108-15. PubMed ID: 19521072
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis: an immunologic perspective.
Cui JY
Phys Med Rehabil Clin N Am; 2005 May; 16(2):351-8. PubMed ID: 15893676
[TBL] [Abstract][Full Text] [Related]
16. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
Tagawa Y; Yuki N
Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
[TBL] [Abstract][Full Text] [Related]
17. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
Hauser SL; Fosburg M; Kevy S; Weiner HL
Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
[TBL] [Abstract][Full Text] [Related]
18. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis.
Liu JF; Wang WX; Xue J; Zhao CB; You HZ; Lu JH; Gu Y
Ther Apher Dial; 2010 Apr; 14(2):153-60. PubMed ID: 20438536
[TBL] [Abstract][Full Text] [Related]
19. [Clinical effectiveness of the method of extracorporeal heparin precipitation of plasma proteins (selective plasmapheresis) in patients with immune complex pathology].
Margulis EIa; Savchenko VG; Vasil'ev SA; Gorodetskiĭ VM; Ryzhko VV
Ter Arkh; 1985; 57(7):125-31. PubMed ID: 2931845
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of plasmapheresis for the treatment of severe toxic epidermal necrolysis: Is cytokine expression analysis useful in predicting its therapeutic efficacy?
Narita YM; Hirahara K; Mizukawa Y; Kano Y; Shiohara T
J Dermatol; 2011 Mar; 38(3):236-45. PubMed ID: 21342225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
